Impact of HLA class I alterations in cancer patients undergoing T cell specific immunotherapy

被引：0
|
作者：
Méndez, R [1 ]
Ruiz-Cabello, F [1 ]
Jiménez, P [1 ]
Cabrera, T [1 ]
López-Nevot, MA [1 ]
Knuth, A [1 ]
Jager, E [1 ]
Traversari, C [1 ]
Schadendorff, D [1 ]
Boon, T [1 ]
Garrido, F [1 ]
机构：
[1] Hosp Univ, Serv Anal Clin, Granada, Spain
来源：
TISSUE ANTIGENS | 2002年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：32 / 32
页数：1
相关论文
共 50 条
  • [1] Identification of Claudin 6-specific HLA class I- and HLA class II-restricted T cell receptors for cellular immunotherapy in ovarian cancer
    Matsuzaki, Junko
    Lele, Shashikant
    Odunsi, Kunle
    Tsuji, Takemasa
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [2] Analysis of HLA class I expression in different metastases from a melanoma patient undergoing T cell immunotherapy.
    Méndez, R
    Rodríguez, T
    Cantón, J
    del Campo, AB
    Ruiz-Cabello, F
    Schadendorf, D
    Garrido, F
    GENES AND IMMUNITY, 2005, 6 : S41 - S41
  • [3] "Hard" and "soft" lesions underlying the HLA Class I alterations in cancer cells: implications for immunotherapy
    Garrido, Federico
    Cabrera, Teresa
    Aptsiauri, Natalia
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (02) : 249 - 256
  • [4] HLA Class-I Expression and Cancer Immunotherapy
    Garrido, Federico
    MHC CLASS-I LOSS AND CANCER IMMUNE ESCAPE, 2019, 1151 : 79 - 90
  • [5] HETEROGENEITY IN CELL SURFACE ANTIGEN AND HLA CLASS I EXPRESSION IN PEDIATRIC BRAIN TUMORS AND ITS IMPACT ON T-CELL IMMUNOTHERAPY
    Houke, Haley
    Zhu, Xiaoyan
    Mercer, Kimberly S.
    Stripay, Jennifer L.
    Chiang, Jason
    Baker, Suzanne
    Roussel, Martine F.
    Gottschalk, Stephen
    Krenciute, Giedre
    NEURO-ONCOLOGY, 2020, 22 : 103 - 103
  • [6] Association of HLA class I genotype with outcomes of gastrointestinal cancer patients with immunotherapy.
    Lu, Zhihao
    Shen, Lin
    Zhang, Henghui
    Jiao, Xi
    Wang, Yujiao
    Zhang, Lei
    Qian, Juanjuan
    Chen, Huan
    Yang, Ying
    Wu, Lijia
    Liu, Chang
    Gong, Jifang
    Li, Jian
    Zhang, Xiaotian
    Wang, Xicheng
    Peng, Zhi
    Qi, Changsong
    Wang, Zhenghang
    Li, Yanyan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Impact of genetic variations and transcriptional alterations of HLA class I genes on cervical cancer pathogenesis
    Das Ghosh, Damayanti
    Mukhopadhyay, Indranil
    Bhattacharya, Amrapali
    Chowdhury, Rahul Roy
    Mandal, Nidhu Ranjan
    Roy, Sudipta
    Sengupta, Sharmila
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (11) : 2498 - 2508
  • [8] γδ T cells are effectors of immunotherapy in cancers with HLA class I defects
    Natasja L. de Vries
    Joris van de Haar
    Vivien Veninga
    Myriam Chalabi
    Marieke E. Ijsselsteijn
    Manon van der Ploeg
    Jitske van den Bulk
    Dina Ruano
    Jose G. van den Berg
    John B. Haanen
    Laurien J. Zeverijn
    Birgit S. Geurts
    Gijs F. de Wit
    Thomas W. Battaglia
    Hans Gelderblom
    Henk M. W. Verheul
    Ton N. Schumacher
    Lodewyk F. A. Wessels
    Frits Koning
    Noel F. C. C. de Miranda
    Emile E. Voest
    Nature, 2023, 613 : 743 - 750
  • [9] γδ T cells are effectors of immunotherapy in cancers with HLA class I defects
    de Vries, Natasja L.
    van de Haar, Joris
    Veninga, Vivien
    Chalabi, Myriam
    Ijsselsteijn, Marieke E.
    van der Ploeg, Manon
    van den Bulk, Jitske
    Ruano, Dina
    van den Berg, Jose G.
    Haanen, John B.
    Zeverijn, Laurien J.
    Geurts, Birgit S.
    de Wit, Gijs F.
    Battaglia, Thomas W.
    Gelderblom, Hans
    Verheul, Henk M. W.
    Schumacher, Ton N.
    Wessels, Lodewyk F. A.
    Koning, Frits
    de Miranda, Noel F. C. C.
    Voest, Emile E.
    NATURE, 2023, 613 (7945) : 743 - 750
  • [10] Analysis of HLA class I expression in different metastases from two melanoma patients undergoing peptide immunotherapy
    Mendez, R
    Serrano, A
    Jäger, E
    Maleno, I
    Ruiz-Cabello, F
    Knuth, A
    Garrido, E
    TISSUE ANTIGENS, 2001, 57 (06): : 508 - 519
12345